Objective: To determine the cumulative incidence and clinical predictors of remote symptomatic seizures and epilepsy after pediatric arterial ischemic stroke (AIS).
Many children with arterial ischemic stroke (AIS) present with acute symptomatic seizures [1] [2] [3] [4] and survivors frequently develop remote symptomatic seizures (RSS) and epilepsy. However, the incidence of these sequelae is unclear, with prior studies of pediatric AIS populations reporting ranges of 13%-67%, varying by age at stroke onset. 2, [5] [6] [7] [8] [9] [10] [11] Moreover, few data are available regarding the risk factors for RSS and epilepsy after pediatric AIS. An improved understanding would help guide family counseling and support the development of approaches to prevent poststroke epilepsy. In this study, we assessed the cumulative incidence and predictors for the development of RSS and epilepsy in infants and children after neonatal AIS (NAIS), presumed perinatal AIS (PPAIS), and childhood-onset AIS (CAIS). This is the first study to directly compare these outcomes across the 3 pediatric AIS subtypes.
METHODS This was a retrospective analysis of a single-center prospective consecutive cohort at the Children's Hospital of Philadelphia (CHOP).
Standard protocol approvals, registrations, and patient consents. The institutional review board approved the study.
Informed consent was obtained for all participants.
Inclusion criteria. The study population comprised 3 groups that presented to CHOP with AIS and were enrolled in the institutional Pediatric Stroke Registry between January 1, 2006, and October 31, 2014. NAIS was diagnosed in term neonates ($37 weeks gestation at birth) with acute neonatal encephalopathy (seizures, altered mental status, or focal neurologic deficits) at #28 days old with acute infarction in an arterial territory on brain MRI (figure 1). PPAIS was diagnosed in children with normal perinatal neurologic histories who developed neurologic deficits or seizures at .28 days old and had remote focal infarction in an arterial territory on MRI. 12 CAIS was diagnosed in children .28 days old with new neurologic deficits or seizures attributable to acute infarction in an arterial territory on MRI or CT. Case ascertainment was thought to be near complete due to an institutional protocol involving stroke service consultation on all AIS cases presenting in both the acute and outpatient care settings. All patients were logged and approached for consent at first point of contact and later at follow-up outpatient visits if consent was not initially obtained. Estimated consent rate was .95% of all participants approached.
Exclusion criteria. Participants with the following comorbidities were excluded: prestroke epilepsy, prematurity (,37 weeks gestation at birth), in utero stroke (detected prenatally or finding of encephalomalacia on MRI at #10 days of age), intracerebral hemorrhage not attributable to hemorrhagic transformation of AIS, cerebral sinovenous thrombosis, periventricular venous infarction, moderate to severe hypoxic-ischemic encephalopathy, congenital hydrocephalus, PHACES, Sturge-Weber syndrome, neonatal moyamoya vasculopathy, cranial surgery, or brain tumor-related infarctions (figure 1).
Data collection. Medical record data were reviewed and entered into a Research Electronic Data Capture database. 13 These included (1) participant demographic and clinical characteristics, (2) time of onset of acute symptomatic seizures, remote symptomatic seizures, and epilepsy, (3) seizure semiology, and (4) antiseizure medication use and duration.
Definitions. An acute symptomatic seizure was defined as any clinically evident seizure observed by a parent/guardian or medical provider or any electrographically evident seizure occurring #7 days after stroke ictus identified by routine EEG or continuous EEG. Clinical seizures in neonates were classified as subtle, clonic, or tonic.
14 An electrographic seizure was defined as any abnormal paroxysmal event different from the EEG background with a temporal-spatial evolution in morphology, frequency, and amplitude, and an electrographic field .10 seconds. 15 An electroclinical seizure was defined as any electrographic seizure associated with observed clinical change. A subclinical seizure was defined as any electrographic seizure that was not associated with observed clinical change. Subacute symptomatic seizures were defined as any seizure occurring between 8 and 29 days after stroke ictus. RSS were defined as any seizure occurring $30 days after stroke ictus. These were classified as provoked seizures, probable epilepsy, or definite epilepsy. Provoked seizures were defined as any seizure occurring with fever or infection. Probable epilepsy was defined as one unprovoked seizure plus one of the following: (1) EEG with epileptiform abnormalities (sharp waves, spike and slow waves) or (2) initiation of treatment with an antiseizure medication. Definite epilepsy was defined as $2 unprovoked seizures occurring $24 hours apart. Status epilepticus in a neonate was defined as a single clinical or electrographic seizure lasting $30 minutes or multiple electrographic or electroclinical seizures totaling $30 minutes of a 60-minute EEG recording. 16 Status epilepticus in a child was defined as any clinical or electrographic seizure lasting .5 minutes. 17 A modified form of the Engel classification 5, 18 was determined for all participants with probable or definite epilepsy where class 0 5 seizure-free off anticonvulsants $6 months, class 1 5 seizure-free $6 months on medication or seizure-free off medication for ,6 months, class Statistical analysis. STATA version 12.0 (Stata Corporation, College Station, TX) was used for all analyses. 20 Fisher exact tests were used to analyze associations for categorical variables. The Wilcoxon rank-sum (WRS) test was used to determine the difference in age of those with and without acute symptomatic seizures in the CAIS cohort. The Kruskal-Wallis (KW) test was used to determine whether follow-up duration, time to RSS among those with RSS, and time to epilepsy among those with epilepsy were different across the CAIS, PPAIS, and NAIS groups. Subsequent pairwise comparisons were performed with the WRS test if the p value for the KW test was significant. The Kaplan-Meier estimate of survival was calculated to determine the RSS-free survival and epilepsy-free survival. Censor time was defined as the time between stroke ictus and last follow-up date for those without RSS or epilepsy (probable and definite) and was the time between stroke ictus and date of the first RSS for those with RSS or epilepsy. Date of stroke ictus was presumed to be date of birth for NAIS and PPAIS. The log-rank test was used to compare Cox proportional hazard ratios (HRs) and evaluate relative risk. A 2-sided probability value of #0.05 was considered statistically significant for all analyses.
RESULTS Overall cohort. A total of 285 Pediatric Stroke Registry cases were examined for eligibility Table 1 Demographic and radiographic characteristics 
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RSS occurred in 17 participants (23%), all of whom had acute seizures. Five participants (7%) developed provoked seizures and one child had an unprovoked seizure at 6.3 years but did not have EEG results available. Eleven participants (15%) developed epilepsy (table 2), in whom 6/11 (55%) had focal epilepsy with or without secondary generalization and 5/11 (45%) had infantile spasms. At time of last follow-up, the median Engel class was 2, and 2/11 participants with epilepsy (18%) had Engel class 0.
Presumed perinatal AIS (n 5 39). Thirty-six participants with PPAIS (92%) were diagnosed due to emerging neurologic signs in infancy. Three were identified after developing RSS: one each with focal seizures, infantile spasms, and status epilepticus. None received an antiseizure medication prior to stroke diagnosis.
RSS occurred in 17/39 participants (44%). Three participants had provoked seizures at 16, 20, and 25 months of age, respectively, and none was treated with antiseizure medication. Fourteen participants (36%) developed definite epilepsy, of whom 11 (79%) had focal epilepsy with or without secondary generalization and 3 (21%) had infantile spasms. At time of last follow-up, the median Engel class was 1 and 2/14 participants with epilepsy (14%) had Engel class 0. RSS occurred in 10/105 participants (10%), with definite epilepsy in 7, probable epilepsy in 2, and a provoked seizure in 1. Seven of 10 with RSS (70%) had acute seizures and 5/10 with RSS (50%) were ,2 years old at stroke ictus. Epilepsy was focal with or without secondary generalization in all participants except one with infantile spasms. At time of last follow-up, the median Engel class was 2 and no participant had Engel class 0.
Group comparisons. Acute symptomatic seizures were more common in NAIS than CAIS, p , 0.001, Fisher exact test. There were similarly high rates of EEG use in both groups (96% vs 83%; p 5 0.10, Fisher exact) and in those with EEG, no differences were found in numbers with electrographic seizures (54% vs 33%, p 5 0.26, Fisher exact test). Moreover, both groups were equally likely to present in status epilepticus, p 5 0.68, Fisher exact test.
Acute seizures could not be analyzed as a predictor of RSS or epilepsy in NAIS as they were present in 95%. In CAIS, those with acute seizures were younger (n 5 18, median age 1.3 years, IQR 5.3, 0.6-5.9) than those without (n 5 87, median age 9.3 years, IQR 9.9, 4.8-14.6, p , 0.0001, Wilcoxon rank sum) and they Median follow-up time was 3.4 years (IQR 1.5-5.7 years) for NAIS, 5.3 years (IQR 2.5-7.5) for PPAIS, and 2 years (IQR 1-3.5) for CAIS, (p 5 0.0001, KW). All subsequent pairwise comparisons were significant with correction for multiple comparisons (not shown). There was no difference among the 3 groups for time to first RSS (p 5 0.42, KW) or epilepsy onset (p 5 0.65, KW).
Kaplan-Meier survival curves for all 3 groups are presented in figure 2. Estimated cumulative incidence of RSS at 2 years was 19% in NAIS, 24% in PPAIS, and 7% in CAIS (table 3). Estimated cumulative incidence of epilepsy at 2 years was 11% in NAIS, 19% in PPAIS, and 7% in CAIS. PPAIS was more likely than CAIS to develop RSS (HR 3.02, 95% CI 1.35-6.72, p 5 0.007) and epilepsy (HR 2.5, 95% CI 1.05-5.95, p 5 0.0038). NAIS showed a trend toward greater risk for RSS than CAIS (HR 2.09, 95% CI 0.95-4.57, p 5 0.07) but not for a greater risk of epilepsy (HR 1.35, 95% CI 0.55-3.28, p 5 0.50).
DISCUSSION While most newborns with NAIS and many children with CAIS have clinical seizures at stroke ictus, we found that RSS and epilepsy later develop in much smaller, though noteworthy proportions. The highest rates of these outcomes were observed in PPAIS, followed by NAIS and CAIS, suggesting that focal neonatal brain injury has a greater propensity for remote seizures than insult later in childhood. While infarcts in NAIS and PPAIS are presumed to occur at the same time perinatally, children with PPAIS are identified after the neonatal period when they present with moderate to severe neurologic deficits or seizures. 12, 21 Those with no or mild impairments may not be diagnosed with stroke or referred to a pediatric stroke service. For these reasons, PPAIS is a stroke subtype participant to clinical referral bias and enriched for adverse neurologic outcomes.
Among perinatal AIS, infarcts in NAIS were more likely to be multifocal and bilateral and PPAIS infarcts more commonly involved the basal ganglia. These findings may suggest that perinatal infarcts with multifocal cortical involvement are more likely to produce acute, clinically detected seizures and that concomitant involvement of cortex and basal ganglia is more likely to result in RSS and epilepsy. 22 Future studies designed to evaluate radiographic predictors of poststroke epilepsy are needed.
Strengths of our study include a well-characterized pediatric AIS cohort without medical comorbidities affecting RSS and epilepsy outcome, prospective and consecutive participant enrollment, rigorous RSS and epilepsy definitions, and inclusion of all 3 pediatric AIS subtypes, allowing for direct comparisons. Our retrospective analysis was limited by single-center participant recruitment, short follow-up, and the small number of children developing RSS and epilepsy. Despite our modest cohort size, this is the largest study reporting RSS and epilepsy outcomes in pediatric AIS. Prior retrospective studies of perinatal AIS with longer follow-up durations have shown higher rates of epilepsy, 6 ,11 though one included preterm participants 11 and another included only children with moderate to severe neuromotor impairments. 6 A recent prospective study of 80 participants with NAIS reported 11% active epilepsy at 7 years poststroke, similar to our NAIS rate at 2 years. 23 The frequency of acute seizures we observed in NAIS and CAIS was similar to previous reports. 1, 4, 9 Overall, acute seizures were much more common in NAIS than in CAIS, and those with acute seizures at CAIS ictus were younger than those without, highlighting the tendency of the younger brain to seize with brain insult. While 85% of our NAIS cohort received antiseizure medication prior to EEG recording, 45% had subclinical seizures. This finding supports the notion that many neonatal seizures are Table 3 Remote symptomatic seizure (RSS) and epilepsy-free survival subclinical 24 and illustrates the phenomenon of neonatal electroclinical dissociation. 25 While we anticipated a high rate of subclinical seizures in NAIS, we were surprised to find that a quarter of CAIS with EEG recording also had subclinical seizures. This observation may support closer encephalographic monitoring of children after stroke.
While acute seizures after NAIS could not be analyzed as a predictor of RSS or epilepsy, we did find that children with acute seizures at CAIS ictus were more likely to develop these outcomes. This parallels a retrospective study of mixed childhood ischemic and hemorrhagic stroke in which those with acute seizures were more likely to have active epilepsy at last follow-up. 2 How acute symptomatic seizures promote RSS and epilepsy in CAIS is unknown, though animal work suggests that seizures may exacerbate preexisting ischemic brain injury. 26 This high-risk population warrants further study as pediatric patients with AIS may be suited to future studies of antiepileptogenic therapies.
Even though half of those developing RSS and epilepsy after CAIS were ,2 years at stroke ictus, we did not find age at time of CAIS to predict later RSS or epilepsy, contrasting with prior work. 2 An explanation for this discrepancy may be that acute seizures at stroke ictus in CAIS are more important to RSS and epilepsy outcome than age per se, though we acknowledge our results may reflect the effect of our aforementioned study limitations on the analysis. Notably, the rate of epilepsy we observed after CAIS closely approximates that reported in young adults (18-50 years) after AIS. 27 Epileptogenesis after acquired brain injury appears to be a continuous process that is age-specific. 28, 29 We found the median time to onset of the first RSS or epilepsy to be similar among the perinatal and childhood AIS subtypes, with both occurring ,2 years after stroke ictus in all 3 groups. This suggests that the cellular and molecular events comprising epileptogenesis follow a similar temporal course from infancy through childhood. In addition, these data imply that studies of antiepileptogenic therapies could be feasible in children since epilepsy appears to develop relatively quickly in some. Larger studies with longer follow-up durations are needed to fully understand the temporal course of epileptogenesis in childhood.
A long-term study of epilepsy in children with hemiplegic cerebral palsy due to NAIS and PPAIS found that the proportion of participants with active epilepsy declined over time and in many cases epilepsy resolved. 6 At last follow-up, we found epilepsy to be well-controlled (Engel class 1 or 2) in most children (n 5 20/34, 59%) and in a small number (n 5 4/34, 12%), epilepsy was no longer active.
While these data support a favorable prognosis for epilepsy after pediatric stroke, the potential for negative consequences should be recognized. A recent study found that children with poststroke epilepsy reported worse health-related quality of life than those without, 30 a finding that underscores the urgent need for new therapies targeting epileptogenesis. Future study of radiographic and electrographic predictors of poststroke seizures and epilepsy may help identify children with a less favorable prognosis and those who will benefit most from clinical trials aimed at preventing acquired epilepsy.
